CEOs Have a Poor View of Britain, Says Pharma Lobby Boss
Britain’s ambition to become a “science superpower” will fail unless the government reverses the country’s reputation as a poor place to invest, the head of the UK’s biggest pharmaceutical lobby group has warned.










